Molecular Minimal Disease in Remission Predicts AML Relapse
Persistence of non - DTA mutations during remission linked to rates of relapse, survival
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pathology, Journal, Source Type: news
More News: Cancer & Oncology | Pathology